PGM5P1: A Potential Drug Target and Biomarker (G653394)

Target Name: Phosphoglucomutase 5 pseudogene 1

NCBI ID: G653394

Phosphoglucomutase 5 pseudogene 1

Other Name(s): PGM5P1

PGM5P1: A Potential Drug Target and Biomarker

Phosphoglucomutase 5 pseudogene 1 (PGM5P1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. The PGM5P1 gene is a member of the phosphoglucomutase family, which is involved in the metabolism of glucose and other nutrients to produce energy.

While the PGM5P1 gene has been studied extensively, much of its function and potential implications for human health remain unexplored. However, research has shown that PGM5P1 is involved in a wide range of physiological processes in the body, including metabolism, inflammation, and cellular signaling.

One of the most promising aspects of PGM5P1 is its potential as a drug target. By inhibiting the activity of PGM5P1, researchers can reduce the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of a variety of diseases.

In addition to its potential as a drug target, PGM5P1 has also been shown to be a potential biomarker for a variety of diseases. For example, researchers have found that PGM5P1 is expressed in a variety of tissues and cells, including cancer cells, and that its expression is associated with the development of cancer.

PGM5P1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for many different cellular processes, including cell growth, differentiation, and inflammation. This suggests that PGM5P1 may play a role in the development and progression of a wide range of diseases.

While more research is needed to fully understand the functions and potential implications of PGM5P1, its potential as a drug target and biomarker make it an important area of study. As research continues to advance, scientists and doctors may find new and innovative ways to use PGM5P1 to treat a variety of diseases.

Protein Name: Phosphoglucomutase 5 Pseudogene 1

The "Phosphoglucomutase 5 pseudogene 1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphoglucomutase 5 pseudogene 1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets